title: Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid streaks.
authors.forename: Ines
authors.initials: I
authors.lastname: Molina Guilabert
authors.forename: Cristina
authors.initials: C
authors.lastname: Calvo-González
authors.forename: Juan
authors.initials: J
authors.lastname: Reche-Frutos
authors.forename: Juan
authors.initials: J
authors.lastname: Donate-López
authors.forename: Julián
authors.initials: J
authors.lastname: García-Feijoó
authors.forename: M
authors.initials: M
authors.lastname: Leila
authors.forename: Julián
authors.initials: J
authors.lastname: García-Sánchez
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000793:Angioid Streaks / Q000150:complications*; D052157:Aptamers, Nucleotide / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology*; D004487:Edema / Q000150:complications / Q000175:diagnosis; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D008297:Male; D012163:Retinal Detachment / Q000150:complications / Q000175:diagnosis; D012164:Retinal Diseases / Q000150:complications / Q000175:diagnosis; D041623:Tomography, Optical Coherence; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D052157:Aptamers, Nucleotide; C495058:pegaptanib